Double or Triple Trouble in Metastatic Hormone-sensitive Prostate Cancer?

Eur Urol Oncol. 2022 Oct;5(5):503-504. doi: 10.1016/j.euo.2022.07.001. Epub 2022 Jul 19.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Androgen Antagonists / therapeutic use
  • Hormones
  • Humans
  • Male
  • Prostatic Neoplasms* / pathology

Substances

  • Androgen Antagonists
  • Hormones